Disease Modeling in Stem Cell-Derived 3D Organoid Systems

Trends in Molecular Medicine

Volumn 23, Issue 5, 2017, Pages 393-410

  Dutta, Devanjali ^a   Heo, Inha ^a   Clevers, Hans ^a,b  

^a HUBRECHT INSTITUTE   (Netherlands)

^b Department of Radiation Oncology   (Netherlands)

Author keywords

cancer; CFTR; infectious disease; microbiota; organoid; personalized medicine; stem cells

Indexed keywords

ADULT STEM CELL; CANCER MODEL; CELL CULTURE TECHNIQUE; CYSTIC FIBROSIS; CYTOPLASM; DISEASE MODEL; EMBRYONIC STEM CELL; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; INFECTION; NONHUMAN; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; REVIEW; STEM CELL; ANIMAL; CYTOLOGY; METABOLISM; NEOPLASM; ORGANOID; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASMS; ORGANOIDS; PLURIPOTENT STEM CELLS;

EID: 85015718933     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2017.02.007     Document Type: Review

References (112)

1. 1 Smith, E., Cochrane, W.J., Cystic organoid teratoma; report of a case. Can. Med. Assoc. J., 55, 1946, 151.
2. 2 Eiraku, M., Sasai, Y., Self-formation of layered neural structures in three-dimensional culture of ES cells. Curr. Opin. Neurobiol. 22 (2012), 768–777.
3. 3 Eiraku, M., et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472 (2011), 51–56.
4. 4 Lancaster, M.A., et al. Cerebral organoids model human brain development and microcephaly. Nature 501 (2013), 373–379.
5. 5 Jo, J., et al. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 19 (2016), 248–257.
6. 6 Dye, B.R., et al. In vitro generation of human pluripotent stem cell derived lung organoids. eLife, 4, 2015, e05098.
7. 7 Takasato, M., et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526 (2015), 564–568.
8. 8 Takebe, T., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499 (2013), 481–484.
9. 9 Song, J.J., et al. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat. Med. 19 (2013), 646–651.
10. 10 Bredenkamp, N., et al. An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts. Nat. Cell Biol. 16 (2014), 902–908.
11. 11 Volkner, M., et al. Retinal organoids from pluripotent stem cells efficiently recapitulate retinogenesis. Stem Cell Rep. 6 (2016), 525–538.
12. 12 Assawachananont, J., et al. Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice. Stem Cell Rep. 2 (2014), 662–674.
13. 13 Aihara, E., et al. Characterization of stem/progenitor cell cycle using murine circumvallate papilla taste bud organoid. Sci. Rep., 5, 2015, 17185.
14. 14 Longworth-Mills, E., et al. Generating inner ear organoids from mouse embryonic stem cells. Methods Mol. Biol. 1341 (2016), 391–406.
15. 15 Spence, J.R., et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470 (2011), 105–109.
16. 16 Huang, S.X., et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32 (2014), 84–91.
17. 17 Evans, M.J., Kaufman, M.H., Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981), 154–156.
18. 18 Thomson, J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998), 1145–1147.
19. 19 Barker, N., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 (2007), 1003–1007.
20. 20 Barker, N., et al. The intestinal stem cell. Genes & Dev. 22 (2008), 1856–1864.
21. 21 Sato, T., et al. Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche. Nature 459 (2009), 262–265.
22. 22 Sato, T., et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141 (2011), 1762–1772.
23. +ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6 (2010), 25–36.
24. + liver stem cells induced by Wnt-driven regeneration. Nature 494 (2013), 247–250.
25. 25 Huch, M., et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. The EMBO J. 32 (2013), 2708–2721.
26. 26 Huch, M., et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160 (2015), 299–312.
27. 27 Boj, S.F., et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160 (2015), 324–338.
28. 28 Karthaus, W.R., et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 159 (2014), 163–175.
29. 29 Bartfeld, S., et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 148 (2015), 126–136.
30. 30 Kessler, M., et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat. Commun., 6, 2015, 8989.
31. 31 Drost, J., et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat. Protoc. 11 (2016), 347–358.
32. 32 Ren, W., et al. Single Lgr5- or Lgr6-expressing taste stem/progenitor cells generate taste bud cells ex vivo. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 16401–16406.
33. 33 Hisha, H., et al. Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells. Sci. Rep., 3, 2013, 3224.
34. 34 Rock, J.R., et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 12771–12775.
35. 35 Hussein, S.M., et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471 (2011), 58–62.
36. 36 Laurent, L.C., et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8 (2011), 106–118.
37. + stem cell. Nat. Med. 18 (2012), 618–623.
38. 38 Koo, B.K., et al. Controlled gene expression in primary Lgr5 organoid cultures. Nat. Methods 9 (2011), 81–83.
39. 39 Grun, D., et al. Single-cell messenger RNA sequencing reveals rare intestinal cell types. Nature 525 (2015), 251–255.
40. 40 Broutier, L., et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat. Protoc. 11 (2016), 1724–1743.
41. 41 Quadrato, G., et al. The promises and challenges of human brain organoids as models of neuropsychiatric disease. Nat. Med. 22 (2016), 1220–1228.
42. 42 Blokzijl, F., et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538 (2016), 260–264.
43. 43 Camp, J.G., et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 15672–15677.
44. 44 Freedman, B.S., et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat. Commun., 6, 2015, 8715.
45. 45 Williams, K.E., et al. Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals. Proc. Natl. Acad. Sci. U.S.A. 113 (2016), E1343–1351.
46. 46 Fatehullah, A., et al. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18 (2016), 246–254.
47. 47 Drost, J., et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521 (2015), 43–47.
48. 48 Schwank, G., et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13 (2013), 653–658.
49. 49 Drost, J., et al. The generation of organoids for studying Wnt signaling. Methods Mol. Biol. 1481 (2016), 141–159.
50. 50 Matano, M., et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21 (2015), 256–262.
51. 51 Bartfeld, S., Clevers, H., Organoids as model for infectious diseases: culture of human and murine stomach organoids and microinjection of Helicobacter pylori. J. Vis. Exp., 2015, 10.3791/53359 Published online November 12, 2015.
52. 52 Wells, M.F., et al. Genetic ablation of AXL does not protect human neural progenitor cells and cerebral organoids from Zika virus infection. Cell Stem Cell 19 (2016), 703–708.
53. 53 Garcez, P.P., et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352 (2016), 816–818.
54. 54 Cugola, F.R., et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534 (2016), 267–271.
55. 55 Leslie, J.L., et al. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect. Immun. 83 (2015), 138–145.
56. 56 Qian, X., et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165 (2016), 1238–1254.
57. 57 Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
58. 58 Yang, J., Weinberg, R.A., Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14 (2008), 818–829.
59. 59 McGranahan, N., Swanton, C., Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27 (2015), 15–26.
60. 60 Clevers, H., The cancer stem cell: premises, promises and challenges. Nat. Med. 17 (2011), 313–319.
61. 61 Sachs, N., Clevers, H., Organoid cultures for the analysis of cancer phenotypes. Curr. Opin. Genet. Dev. 24 (2014), 68–73.
62. 62 Delpu, Y., et al. Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr. Genom. 12 (2011), 15–24.
63. 63 Huang, L., et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat. Med. 21 (2015), 1364–1371.
64. 64 Baker, L.A., et al. Modeling pancreatic cancer with organoids. Trends Cancer 2 (2016), 176–190.
65. 65 Wills, E.S., Drenth, J.P., Building pancreatic organoids to aid drug development. Gut 66 (2016), 393–394.
66. 66 Gao, D., et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159 (2014), 176–187.
67. 67 Hubert, C.G., et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 76 (2016), 2465–2477.
68. 68 van de Wetering, M., et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161 (2015), 933–945.
69. 69 Fujii, M., et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18 (2016), 827–838.
70. 70 Riordan, J.R., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989), 1066–1073.
71. 71 Stutts, M.J., et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269 (1995), 847–850.
72. 72 Gilljam, M., et al. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 126 (2004), 1215–1224.
73. 73 Perez-Aguilar, F., et al. Digestive alterations in cystic fibrosis. Retrospective study of a series of 46 adult patients. Gastroenterol. Hepatol. 22 (1999), 72–78 (in Spanish).
74. 74 Ooi, C.Y., Durie, P.R., Cystic fibrosis from the gastroenterologist's perspective. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 175–185.
75. 75 Cutting, G.R., Cystic fibrosis genetics: from molecular understanding to clinical application. Nat. Rev. Genet. 16 (2015), 45–56.
76. 76 Dekkers, J.F., et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19 (2013), 939–945.
77. 77 Dekkers, J.F., et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci. Transl. Med., 8, 2016, 344ra384.
78. 78 Hohwieler, M., et al. Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling. Gut, 2016, 10.1136/gutjnl-2016-312423 Published online September 15, 2016.
79. 79 Firth, A.L., et al. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep. 12 (2015), 1385–1390.
80. 80 Bartfeld, S., Modeling infectious diseases and host–microbe interactions in gastrointestinal organoids. Devel. Biol. 420 (2016), 262–270.
81. 81 Dang, J., et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell 19 (2016), 258–265.
82. 82 Lancaster, M.A., Knoblich, J.A., Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9 (2014), 2329–2340.
83. 83 Nowakowski, T.J., et al. Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell 18 (2016), 591–596.
84. 84 O'Ryan, M., et al. A millennium update on pediatric diarrheal illness in the developing world. Semin. Pediatr. Infect. Dis. 16 (2005), 125–136.
85. 85 Wilhelmi, I., et al. Viruses causing gastroenteritis. Clin. Microbiol. Infect. 9 (2003), 247–262.
86. 86 Finkbeiner, S.R., et al. Stem cell-derived human intestinal organoids as an infection model for rotaviruses. mBio 3 (2012), e00159–00112.
87. 87 Yin, Y., et al. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antiviral Res. 123 (2015), 120–131.
88. 88 Ettayebi, K., et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 353 (2016), 1387–1393.
89. 89 Klotz, C., et al. Stem cell-derived cell cultures and organoids for protozoan parasite propagation and studying host–parasite interaction. Int. J. Med. Microbiol. 302 (2012), 203–209.
90. 90 Tao, L., et al. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538 (2016), 350–355.
91. 91 Forbester, J.L., et al. Interaction of Salmonella enterica serovar Typhimurium with intestinal organoids derived from human induced pluripotent stem cells. Infect. Immun. 83 (2015), 2926–2934.
92. 92 Zhang, Y.G., et al. Salmonella-infected crypt-derived intestinal organoid culture system for host–bacterial interactions. Physiol. Rep., 2, 2014, e12147.
93. 93 Scanu, T., et al. Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma. Cell Host Microbe 17 (2015), 763–774.
94. 94 Huang, J.Y., et al. Chemodetection and destruction of host urea allows Helicobacter pylori to locate the epithelium. Cell Host Microbe 18 (2015), 147–156.
95. 95 Amieva, M., Peek, R.M. Jr., Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology 150 (2016), 64–78.
96. 96 McCracken, K.W., et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516 (2014), 400–404.
97. 97 Arnold, J.W., et al. Emerging technologies for gut microbiome research. Trends Microbiol. 24 (2016), 887–901.
98. 98 Nigro, G., et al. The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration. Cell Host Microbe 15 (2014), 792–798.
99. 99 Lukovac, S., et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio, 5, 2014 e01438–14.
100. 100 Park, J.H., et al. Promotion of intestinal epithelial cell turnover by commensal bacteria: role of short-chain fatty acids. PloS One, 11, 2016, e0156334.
101. 101 Engevik, M.A., et al. Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth. Am. J. Physiol. Gastrointest. Liver Physiol. 305 (2013), G697–711.
102. 102 Kaiko, G.E., et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell, 167, 2016, 1137.
103. 103 Pham, T.A., et al. Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16 (2014), 504–516.
104. 104 Farin, H.F., et al. Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-gamma. J. Exp. Med. 211 (2014), 1393–1405.
105. 105 Gjorevski, N., et al. Designer matrices for intestinal stem cell and organoid culture. Nature 539 (2016), 560–564.
106. 106 Mariani, J., et al. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell 162 (2015), 375–390.
107. 107 Dotti, I., et al. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. Gut, 2016, 10.1136/gutjnl-2016-312609 Published online November 1, 2016.
108. 108 Hibiya, S., et al. Long-term inflammation transforms intestinal epithelial cells of colonic organoids. J. Crohns Colitis, 2016, 10.1093/ecco-jcc/jjw186 Published online October 11, 2016.
109. 109 Miner, J.J., Diamond, M.S., Understanding how Zika virus enters and infects neural target cells. Cell Stem Cell 18 (2016), 559–560.
110. 110 Xu, M., et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat. Med. 22 (2016), 1101–1107.
111. 111 Boj, S.F., et al. Model organoids provide new research opportunities for ductal pancreatic cancer. Mol. Cell. Oncol., 3, 2016, e1014757.
112. 112 Tapia, N., Scholer, H.R., Molecular obstacles to clinical translation of iPSCs. Cell Stem Cell 19 (2016), 298–309.